======= JMY =======
== Gene Information ==
* **Official Symbol**: JMY
* **Official Name**: junction mediating and regulatory protein, p53 cofactor
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=133746|133746]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q8N9B5|Q8N9B5]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=JMY&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20JMY|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/604279|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Acts both as a nuclear p53/TP53-cofactor and a cytoplasmic regulator of actin dynamics depending on conditions. In nucleus, acts as a cofactor that increases p53/TP53 response via its interaction with p300/EP300. Increases p53/TP53-dependent transcription and apoptosis, suggesting an important role in p53/TP53 stress response such as DNA damage. In cytoplasm, acts as a nucleation-promoting factor for both branched and unbranched actin filaments. Activates the Arp2/3 complex to induce branched actin filament networks. Also catalyzes actin polymerization in the absence of Arp2/3, creating unbranched filaments. Contributes to cell motility by controlling actin dynamics. May promote the rapid formation of a branched actin network by first nucleating new mother filaments and then activating Arp2/3 to branch off these filaments. The p53/TP53-cofactor and actin activator activities are regulated via its subcellular location (By similarity). {ECO:0000250}.
No Pfam Domain information is available for this gene.
|de novo actin filament nucleation|
|actin polymerization-dependent cell motility|
|Arp2/3 complex binding|
|Arp2/3 complex-mediated actin nucleation|
|actin nucleation|
|cell leading edge|
|intrinsic apoptotic signaling pathway by p53 class mediator|
|positive regulation of actin filament polymerization|
|signal transduction by p53 class mediator|
|positive regulation of protein polymerization|
|cell cycle arrest|
|intrinsic apoptotic signaling pathway|
|regulation of actin filament polymerization|
|regulation of signal transduction by p53 class mediator|
|regulation of actin polymerization or depolymerization|
|regulation of actin filament length|
|positive regulation of supramolecular fiber organization|
|positive regulation of cytoskeleton organization|
|regulation of protein polymerization|
|actin filament organization|
|positive regulation of protein complex assembly|
|regulation of actin filament organization|
|positive regulation of DNA-binding transcription factor activity|
|actin binding|
|apoptotic signaling pathway|
|transcription coactivator activity|
|regulation of actin cytoskeleton organization|
|regulation of supramolecular fiber organization|
|cytoskeleton|
|regulation of cellular component size|
|regulation of actin filament-based process|
|regulation of DNA-binding transcription factor activity|
|regulation of protein complex assembly|
|supramolecular fiber organization|
|actin cytoskeleton organization|
|DNA repair|
|regulation of anatomical structure size|
|positive regulation of cellular component biogenesis|
|regulation of cytoskeleton organization|
|actin filament-based process|
|negative regulation of cell cycle|
|positive regulation of organelle organization|
|positive regulation of apoptotic process|
|positive regulation of programmed cell death|
|positive regulation of cell death|
|DNA metabolic process|
|cellular response to DNA damage stimulus|
|apoptotic process|
|regulation of cellular component biogenesis|
|cell cycle process|
|programmed cell death|
|localization of cell|
|cell motility|
|cell death|
|cytoskeleton organization|
|regulation of cell cycle|
|positive regulation of cellular component organization|
|regulation of organelle organization|
|locomotion|
|cell cycle|
|regulation of apoptotic process|
|movement of cell or subcellular component|
|regulation of programmed cell death|
|positive regulation of nucleic acid-templated transcription|
|positive regulation of RNA biosynthetic process|
|regulation of cell death|
|intracellular signal transduction|
|cellular response to stress|
|positive regulation of RNA metabolic process|
|positive regulation of molecular function|
|regulation of intracellular signal transduction|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of macromolecule biosynthetic process|
|positive regulation of cellular biosynthetic process|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp185|L-BMAA 500 to 750μM on day4 R04 exp185]]|-1.79|
|[[:results:exp217|Mdivi-1 15μM R05 exp217]]|1.77|
|[[:results:exp246|UM0011500 10μM R05 exp246]]|1.78|
|[[:results:exp99|NFN1 0.4μM R03 exp99]]|1.92|
|[[:results:exp95|BI-2536 0.0042μM R03 exp95]]|1.98|
|[[:results:exp83|Trametinib 10μM R02 exp83]]|1.98|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/25|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/15|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 9974
* **Expression level (log2 read counts)**: 5.58
{{:chemogenomics:nalm6 dist.png?nolink |}}